Clinical Trials Browser

Has results × Microarray Analysis × Plasma cell × Clear all

NCT00520767 2023-12-22

Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease

Phase 2 Completed

35 enrolled 7 charts

Immunoglobulin Light-chain Amyloidosis

NCT00567229 2015-11-20

Lenalidomide and Rituximab in Treating Patients With Recurrent and/or Refractory Multiple Myeloma

Phase 2 Terminated

3 enrolled 6 charts

Multiple Myeloma, Neoplasms, Plasma Cell